MFG-E8-Derived Oligopeptide MOP3 Facilitates Anti-Inflammatory M2-like Macrophage Polarization in Gut Ischemia/Reperfusion
Cells · 29.03.2026 · 15 (7) · 606
DOI: 10.3390/cells15070606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 29.03.2026. Verfasst von Russell Hollis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA. Hauptthemen laut MEDLINE: Reperfusion Injury, Milk Proteins, Antigens, Surface, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH Common Fund, National Institutes of Health (NIH) https://ror.org/01cwqze88.
Abstract (Originalsprache)
Gut ischemia/reperfusion (I/R) injury releases damage-associated molecular patterns (DAMPs), such as extracellular cold-inducible RNA-binding protein (eCIRP). Milk fat globule–epidermal growth factor VIII-derived oligopeptide 3 (MOP3) is a novel peptide enabling macrophage uptake of eCIRP via αvβ3-integrin. MOP3 reduces inflammation in gut I/R, but its mechanisms are not completely understood. We hypothesized MOP3 promotes macrophage polarization toward an anti-inflammatory, M2-like phenotype in gut I/R. We induced gut I/R in mice through 60 min of superior mesenteric artery occlusion followed by 4 h of reperfusion. Intestines were evaluated for macrophage polarization by flow cytometry and immunofluorescence histology. Peritoneal cavity macrophages were isolated from mice and treated with eCIRP, MOP3, αvβ3-antibody, and/or naïve IgG for 4 or 24 h. Polarity was assessed by flow cytometry, qPCR, and ELISA. Compared to the sham, the M2 proportion after gut I/R decreased by 22.7%, and the M1 proportion increased by 241%. MOP3 treatment increased the M2 proportion by 64.3%, and the M1 proportion decreased by 22.7%. In eCIRP-stimulated macrophages, MOP3 treatment increased M2-like and reduced M1-like cell-surface markers, gene expression, and cytokine levels. αvβ3 antibody dramatically reduced MOP3′s effects. MOP3 promotes M2 polarization through αvβ3 integrin-mediated clearance of eCIRP, a novel mechanism whereby MOP3 reduces gut I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA.
- Department of Surgery, Zucker School of Medicine, Manhasset, NY 11030, USA.
- Elmezzi Graduate School of Molecular Medicine, Northwell Health, Manhasset, NY 11030, USA.
ORCID-Profile: Russell Hollis, Megan Tenet, Monowar Aziz, Ping Wang
Förderung
- NIH Common Fund
- National Institutes of Health (NIH) https://ror.org/01cwqze88
Zitieren
APA
Hollis, R., Akama, Y., Lee, Y., Li, J., Tenet, M., Aziz, M., & Wang, P. (2026). MFG-E8-Derived Oligopeptide MOP3 Facilitates Anti-Inflammatory M2-like Macrophage Polarization in Gut Ischemia/Reperfusion. Cells, 15(7), 606. https://doi.org/10.3390/cells15070606
Vancouver
Hollis R, Akama Y, Lee Y, Li J, Tenet M, Aziz M, et al. MFG-E8-Derived Oligopeptide MOP3 Facilitates Anti-Inflammatory M2-like Macrophage Polarization in Gut Ischemia/Reperfusion. Cells. 2026;15(7):606. doi:10.3390/cells15070606
BibTeX
@article{Hollis2026,
author = {Hollis, Russell and Akama, Yuichi and Lee, Yongchan and Li, Jingsong and Tenet, Megan and Aziz, Monowar and Wang, Ping},
title = {MFG-E8-Derived Oligopeptide MOP3 Facilitates Anti-Inflammatory M2-like Macrophage Polarization in Gut Ischemia/Reperfusion},
journal = {Cells},
year = {2026},
volume = {15},
number = {7},
pages = {606},
doi = {10.3390/cells15070606}
}
EUVIMED